Analyst picks & changes

ProCyte Corp.

(PRCY)

Wertheim Schroder analyst Jay Silverman initiated coverage with a "buy" rating and added the

Read the full 175 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE